A novel clinician interface to improve clinician access to up-to-date genetic results

Journal of the American Medical Informatics Association

Volumn 21, Issue E2, 2014, Pages

  Wilcox, Allison R ^a,b   Neri, Pamela M ^a   Volk, Lynn A ^a   Newmark, Lisa P ^a   Clark, Eugene H ^a   Babb, Lawrence J ^a   Varugheese, Matthew ^a   Aronson, Samuel J ^a   Rehm, Heidi L ^c,d,e   Bates, David W ^a,c,e  

^a PARTNERS HEALTHCARE   (United States)

^b University of Louisville School of Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d LABORATORY FOR MOLECULAR MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; E-MAIL; GENETIC INFORMATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL RECORD; MEDICAL STAFF; OUTCOME ASSESSMENT;

GENETICS; LABORATORY SOFTWARE; MEDICAL INFORMATICS APPLICATIONS;

COMMUNICATION; ELECTRONIC MAIL; GENETIC TESTING; HUMANS; INTERNET; TIME FACTORS;

EID: 84893569478     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2013-001965     Document Type: Article

References (15)

1. Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:2143-53.
2. Hindorff LA, MacArthur J, Wise A, et al. A Catalog of Published Genome-Wide Association Studies 2012. http://www.genome.gov/gwastudies/(accessed 18 Mar 2013).
3. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352:362-72.
4. Bean LJ, Tinker SW, da Silva C, et al. Free the data: one laboratory's approach to knowledge-based genomic variant classification and preparation for EMR integration of genomic data. Hum Mutat 2013;34(9):1183-8.
5. Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011;3:65ra4.
6. Xue Y, Chen Y, Ayub Q, et al. Deleterious-and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet 2012;91:1022-32.
7. Norton N, Robertson PD, Rieder MJ, et al. Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet 2012;5:167-74.
8. Weng L, Kavaslar N, Ustaszewska A, et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest 2005;115:1016-20.
9. Hunt KA, Smyth DJ, Balschun T, et al. Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nature Genet 2012;44:3-5.
10. Richards CS, Bale S, Bellissimo DB, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007. Genet Med 2008;10:294-300.
11. Aronson SJ, Clark EH, Babb LJ, et al. The GeneInsight suite: a platform to support laboratory and provider use of DNA-based genetic testing. Hum Mutat 2011;32:532-6.
12. Aronson SJ, Clark EH, Varugheese M, et al. Communicating new knowledge on previously reported genetic variants. Genet Med 2012;14:713-19.
13. Neri PM, Pollard SE, Volk LA, et al. Usability of a novel clinician interface for genetic results. J Biomed Inform 2012;45:950-7.
14. Plon SE, Eccles DM, Easton D, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 2008;29:1282-91.
15. Kearney HM, Thorland EC, Brown KK, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680-5.